MoneyWorks4Me

Indoco Remedies - Quaterly Results

29 Jul 2026 Evaluate
The total revenue for the quarter ended June 2026 remained nearly unchanged at Rs. 4089.70 millions.The Total Profit for the quarter ended June 2026 of Rs. 823.20 millions grew from Rs.-280.70 millionsOP of the company witnessed a marginal growth to 466.80 millions from 204.00 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 4089.70 3943.10 3.72 4089.70 3943.10 3.72 16860.70 15181.90 11.06
Other Income 44.70 55.80 -19.89 44.70 55.80 -19.89 296.40 184.80 60.39
PBIDT 466.80 204.00 128.82 466.80 204.00 128.82 1867.90 1465.20 27.48
Interest 227.50 236.10 -3.64 227.50 236.10 -3.64 885.00 566.30 56.28
PBDT 1212.70 -32.10 -3877.88 1212.70 -32.10 -3877.88 954.30 908.80 5.01
Depreciation 280.50 252.00 11.31 280.50 252.00 11.31 1069.00 982.50 8.80
PBT 932.20 -284.10 -428.12 932.20 -284.10 -428.12 -114.70 -73.70 55.63
TAX 109.00 -3.40 -3305.88 109.00 -3.40 -3305.88 -58.10 13.60 -527.21
Deferred Tax 3.40 -3.40 -200.00 3.40 -3.40 -200.00 -87.30 13.60 -741.91
PAT 823.20 -280.70 -393.27 823.20 -280.70 -393.27 -56.60 -87.30 -35.17
Equity 184.60 184.50 0.05 184.60 184.50 0.05 184.60 184.50 0.05
PBIDTM(%) 11.41 5.17 120.62 11.41 5.17 120.62 11.08 9.65 14.79
Peers
Company Name CMP
Sun Pharma. Inds. 1851.00
Dr. Reddys Labs. 1143.30
Cipla 1368.65
Lupin 2075.20
Zydus Lifesciences 1118.00
View more..